
Shanmugam Muthusamy
About Shanmugam Muthusamy
Data last updated:
Shanmugam Muthusamy is a Director at Saimirra Innopharm Private Limited (since 2012), Director at Nuray Chemicals Private Limited (since 2016) and Director at Scitus Pharma Services Private Limited (since 2017), and holds 6 more current directorships. The companies operate in Pharma and Energy. The 8 current companies with reported revenue have a combined latest revenue of ₹341 Cr; the largest is Saimirra Innopharm Private Limited at ₹133 Cr (FY 2025). Earlier, Shanmugam Muthusamy was a Director at Par Formulations Private Limited (2009–2012) and Director at Delvin Formulations Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Oct 2012 | 2000 | ₹133 Cr (FY 2025) | Active | |
| Director | 20 Jul 2016 | 2012 | ₹122 Cr (FY 2025) | Active | |
| Director | 26 Sep 2017 | 2017 | ₹43.45 Cr (FY 2025) | Active | |
| Director | 15 Sep 2016 | 2016 | ₹33.80 Cr (FY 2025) | Active | |
| Director | 01 Jul 2024 | 2022 | ₹3.90 Cr (FY 2024) | Active | |
| Director | 10 Aug 2022 | 2020 | ₹3.11 Cr (FY 2024) | Active | |
| Director | 06 Oct 2017 | 2015 | ₹1.46 Cr (FY 2024) | Active | |
| Director | 07 Jan 2022 | 2022 | ₹43,990 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Jun 2009 | 1982 | ₹1,462 Cr (FY 2025) | Active | |
| Director | 24 Jul 2009 | 2009 | ₹30.87 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shanmugam Muthusamy
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shanmugam Muthusamy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shanmugam Muthusamy
Shanmugam Muthusamy currently holds 9 directorships: Saimirra Innopharm Private Limited (Director, since 22 Oct 2012, revenue ₹133 Cr (FY 2025)); Nuray Chemicals Private Limited (Director, since 20 Jul 2016, revenue ₹122 Cr (FY 2025)); Scitus Pharma Services Private Limited (Director, since 26 Sep 2017, revenue ₹43.45 Cr (FY 2025)); Novitium Labs Private Limited (Director, since 15 Sep 2016, revenue ₹33.80 Cr (FY 2025)); Esjay Pharma Private Limited (Director, since 01 Jul 2024, revenue ₹3.90 Cr (FY 2024)); and 4 more.
Shanmugam Muthusamy was first appointed on 29 Jun 2009 as Director at Par Formulations Private Limited. The most recent appointment on record is 01 Jul 2024 at Esjay Pharma Private Limited.
The 8 current companies of Shanmugam Muthusamy that report revenue have a combined latest revenue of ₹341 Cr: Saimirra Innopharm Private Limited ₹133 Cr (FY 2025); Nuray Chemicals Private Limited ₹122 Cr (FY 2025); Scitus Pharma Services Private Limited ₹43.45 Cr (FY 2025); Novitium Labs Private Limited ₹33.80 Cr (FY 2025); Esjay Pharma Private Limited ₹3.90 Cr (FY 2024); and 3 more.
Shanmugam Muthusamy held 2 earlier board appointments: Par Formulations Private Limited (Director, 29 Jun 2009 to 17 Feb 2012); Delvin Formulations Private Limited (Director, from 24 Jul 2009).
The current boards of Shanmugam Muthusamy's companies include Abhishek Jain (Saimirra Innopharm Private Limited), Anushree Manmohan Chandak (Saimirra Innopharm Private Limited), Ayyavu Rajavel (Saimirra Innopharm Private Limited), Bernice Sugirtha (Saimirra Innopharm Private Limited), Jaganathan Jayaseelan (Saimirra Innopharm Private Limited), Thanigainathan Thirumurugan (Saimirra Innopharm Private Limited), among others.